ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Safety and Efficacy of the Levonorgestrel-Releasing Intrauterine System in Transplant Patients

    T. Nizamic, A. Amies Oelschlager, K. Debiec, J. Smith, E. Micks, S. Prager

    Obstetrics and Gynecology, University of Washington, Seattle, WA; Pediatric and Adolescent Gynecology, Seattle Children's Hospital, Seattle, WA

    Introduction: The levonorgestrel intrauterine contraceptive system (LNG-IUS) is safe and effective for contraception, dysmenorrhea, and treatment of heavy menstrual bleeding. Safety and efficacy has been…
  • 2013 American Transplant Congress

    Kidney Transplant Volume and Outcomes Trends in the Era Surrounding Initiation of the Medicare Conditions of Participation

    S. White, D. Zinsser, M. Paul, G. Levine, T. Shearon, V. Ashby, J. Magee, A. Leichtman

    KECC, University of Michigan, Ann Arbor; Dept of Medicine, University of Michigan, Ann Arbor; Dept of Surgery, University of Michigan, Ann Arbor

    Background: In mid-2007, the Centers for Medicare and Medicaid Services (CMS) implemented Conditions of Participation for organ transplant programs, under which programs not attaining specified…
  • 2013 American Transplant Congress

    NK Depletion Reduces Murine Cytomegalovirus Induced Renal Allograft Injury Despite Increased Viral Loads in a Murine Transplant Model

    M. Shimamura, L. Guo, J. George, T. Schoeb, W. Britt

    Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL; Cardiovascular/Thoracic Surgery, University of Alabama at Birmingham, Birmingham, AL; Genetics, University of Alabama at Birmingham, Birmingham, AL

    PURPOSE: NK cell activation is induced by viral infection and has been associated with renal allograft injury in clinical populations and animal models, so this…
  • 2013 American Transplant Congress

    How Do Anhepatic Patients Fair? A Single-Center Experience of Thirteen Patients Requiring Total Hepatectomy and Portocaval Shunting for Severe Hepatic Dysfunction

    K. Lau, A. Zarrinpar, V. Agopian, F. Kaldas, D. Farmer, R. Busuttil

    Department of Surgery, The Dumont-UCLA Liver Transplant Center, Los Angeles, CA

    BACKGROUND/AIMS:Total hepatectomy with portocaval shunting (TH-PS) is a last-resort in patients with severe acute liver dysfunction awaiting liver transplantation (LT). The anhepatic state portends dismal…
  • 2013 American Transplant Congress

    Eculizumab (Anti-C5) for Treatment of Severe Antibody-Mediated Rejection (ABMR) and Recurrent C3 Glomerulonephritis in Renal Allografts: A Single Center Experience

    S. Jordan, J. Choi, R. Villicana, A. Peng, J. Kahwaji, R. Najjar, A. Vo

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

    INTRODUCTION: ABMR is a severe form of allograft injury mediated, primarily, by antibody-induced complement activation. Complement activation through the alternate pathway may also result in…
  • 2013 American Transplant Congress

    Long-Term Impact of a Pancreas Graft on a Previously Transplanted Kidney

    A. Gruessner, R. Gruessner

    College of Public Health, University of Arizona, Tucson, AZ; Department of Surgery, University of Arizona, Tucson, AZ

    Introduction]: While pancreas after kidney (PAK) transplant allow for pre-emptive kidney transplant and reduced waiting times, there is concern that the additional ‘burden' of the…
  • 2013 American Transplant Congress

    Successful Transplantation of Kidney Allografts in Sensitized Rats Made Possible by Autologous Hematopoietic Stem Cell Transplantation (HSCT) and Fludarabine

    Y. Fu, R. Montgomery, Y. Wang, E. Fuchs, Z. Shen, G. Williams, Z. Sun

    Johns Hopkins University School of Medicine, Baltimore; Tianjin First Central Hospital and Tianjin Medical University, Tianjin, China

    We tested whether resetting the immune system with autologous HSC after preconditioning with Fludarabine improves kidney allograft survival in sensitized hosts.Methods: MHC mismatched DA (RT1Aa)…
  • 2013 American Transplant Congress

    Barriers for Seniors To Get Listed for Kidney Transplantation

    S. Bolourani, L. Lindquist, B. Lapin, D. Ladner

    Northwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center, Northwestern University, Chicago; Rosalind Franklin University School of Medicine and Science, Chicago Medical School, North Chicago; General Internal Medicine, Northwestern University, Chicago

    Introduction: Kidney transplant (KT) provides patients with improved survival rate and higher quality of life measures, and impose a significantly lower cost on Medicare when…
  • 2013 American Transplant Congress

    Long-Term Calcineurin Inhibitor (CNI) and Corticosteroid (CS) Avoidance Using Belatacept: The CTOT-10 Experience

    K. Newell, R. Mannon, A. Mehta, S. Tomlanovich, Y. Morrison, D. Ikle, J. Goodman, S. Mehta, N. Bridges, P. Stock, C. Larsen

    Emory Transplant Center; Univ of Alabama-Birmingham; UC-San Francisco; NIAID/NIH; Rho

    Belatacept is approved a component of a CNI-free immunosuppressive regimen in EBV + adults undergoing renal transplantation. The intent of this NIH-sponsored CTOT study was…
  • 2013 American Transplant Congress

    Good Second Kidney Transplant Outcomes in Pediatric Patients with Early First Kidney Graft Loss

    M. Gupta, A. Wood, N. Mitra, S. Furth, P. Abt, M. Levine

    Department of Surgery, Division of Transplantation, University of Pennsylvania, Philadelphia, PA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Department of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA

    Intro:Pediatric kidney transplant (KTx) recipients with early first kidney graft loss(within 30 days) may have graft failure from technical complications or patient disease(hypercoagulability, acute rejection,…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences